title: Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice.
abstract: Attenuated bacteria have long been developed as vaccine candidates but can have some disadvantages, such as the potential for damage to immune organs due to insufficient clearance. To minimize these disadvantages, we generated Salmonella enterica serovar Typhimurium mutants SHJ2104 (asd::cm) and HTSaYA (wzy::km, asd::cm). The wzy gene codes for the O-antigen polymerase, which is involved in lipopolysaccharide (LPS) biosynthesis, and asd codes for aspartate beta-semialdehyde dehydrogenase, which participates in cell wall formation. The strains synthesized LPS with a short-chain length, and showed lower cytotoxicity and reduced intracellular proliferation in animal cells compared to wild-type bacteria. After oral infection, the mutants were cleared in immune tissues, including the Peyer's patch, mesenteric lymph node, and spleen, within 5 days. The LD50 of the mutants in Balb/c mice was estimated to be 10(6) higher than wild-type bacteria when administered either via an oral or i.p. route, indicating that the two strains are highly attenuated. To compare the immune response to and protective effects of the mutants against wild-type bacterial infection, we inoculated the mutants into mice via an oral (1x10(10)CFU) or i.p. (1x10(7) CFU) route once or twice at a two week interval. All immune responses, such as serum IgG and secretory IgA levels, cytokine production, and delayed hypersensitivity, were highly induced by two rounds of immunization. HTSaYA and SHJ2104 induced similar immune responses, and mice immunized with HTSaYA or SHJ2104 via an i.p. route were protected against wild-type Salmonella infection even at 100-fold of the LD(50) (5x10(6) CFU). Taken together, these data indicate that HTSaYA and SHJ2104 could be developed as live attenuated Salmonella vaccine candidates.
authors.affiliation: Clinical Vaccine R&D Center, Chonnam National University Medical School, Gwangju, Republic of Korea.
authors.forename: Hong Hua
authors.initials: HH
authors.lastname: Piao
authors.forename: Vo Thi Minh
authors.initials: VT
authors.lastname: Tam
authors.forename: Hee Sam
authors.initials: HS
authors.lastname: Na
authors.forename: Hyun Ju
authors.initials: HJ
authors.lastname: Kim
authors.forename: Phil Youl
authors.initials: PY
authors.lastname: Ryu
authors.forename: Soo Young
authors.initials: SY
authors.lastname: Kim
authors.forename: Joon Haeng
authors.initials: JH
authors.lastname: Rhee
authors.forename: Hyon E
authors.initials: HE
authors.lastname: Choy
authors.forename: Suhng Wook
authors.initials: SW
authors.lastname: Kim
authors.forename: Yeongjin
authors.initials: Y
authors.lastname: Hong
mesh_terms: D000594:Amino Acid Oxidoreductases / Q000235:genetics / Q000276:immunology*; D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology*; D002460:Cell Line; D004195:Disease Models, Animal; D005260:Female; D006602:Hexosyltransferases / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C; D009154:Mutation; D012480:Salmonella Infections / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D022562:Salmonella Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D012486:Salmonella typhimurium / Q000235:genetics / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D022562:Salmonella Vaccines; D014613:Vaccines, Attenuated; D000594:Amino Acid Oxidoreductases; C025745:aspartate dehydrogenase; D006602:Hexosyltransferases; C085652:O-antigen polymerase
references.citation: J Biol Chem. 2004 Aug 13;279(33):34183-90
references.pmid: 15161921
references.citation: Infect Immun. 1976 Oct;14(4):851-7
references.pmid: 791864
references.citation: Infect Immun. 2002 Apr;70(4):1739-49
references.pmid: 11895935
references.citation: FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):99-104
references.pmid: 12832112
references.citation: J Microbiol Methods. 2006 Jan;64(1):17-26
references.pmid: 15927288
references.citation: Infect Immun. 2008 Nov;76(11):5238-46
references.pmid: 18765737
references.citation: Annu Rev Biochem. 2002;71:635-700
references.pmid: 12045108
references.citation: Immunology. 1995 Jan;84(1):8-15
references.pmid: 7890306
references.citation: Microb Pathog. 1987 Aug;3(2):129-41
references.pmid: 2849016
references.citation: Infect Immun. 1997 Jul;65(7):2821-8
references.pmid: 9199455
references.citation: Bacteriol Rev. 1972 Dec;36(4):407-77
references.pmid: 4568761
references.citation: Infect Immun. 1991 Mar;59(3):1079-85
references.pmid: 1997412
references.citation: J Exp Med. 1974 May 1;139(5):1189-203
references.pmid: 4596512
references.citation: Trends Microbiol. 1998 Apr;6(4):131-3
references.pmid: 9587187
references.citation: J Immunol Methods. 1990 Jan 24;126(1):109-17
references.pmid: 2106001
references.citation: Microbiol Immunol. 1991;35(4):331-3
references.pmid: 1719357
references.citation: Vaccine. 2006 Mar 15;24(12):2027-34
references.pmid: 16356600
references.citation: Bull World Health Organ. 1964;30:623-30
references.pmid: 14196811
references.citation: Mol Microbiol. 2003 Mar;47(5):1395-406
references.pmid: 12603743
references.citation: Gene. 1990 Sep 28;94(1):29-35
references.pmid: 2227450
references.citation: J Clin Invest. 1994 Sep;94(3):1328-32
references.pmid: 8083373
references.citation: Vaccine. 1991 Nov;9(11):810-6
references.pmid: 1759503
references.citation: Infect Immun. 1995 Dec;63(12):4557-63
references.pmid: 7591105
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
references.pmid: 10829079
references.citation: Infect Immun. 1989 Sep;57(9):2758-63
references.pmid: 2668186
references.citation: Infect Immun. 1999 Sep;67(9):4320-5
references.pmid: 10456869
references.citation: Infect Immun. 1997 Dec;65(12):5381-7
references.pmid: 9393846
references.citation: Infect Immun. 1985 Oct;50(1):152-9
references.pmid: 3899931
references.citation: Infect Immun. 2006 Mar;74(3):1555-64
references.pmid: 16495526
references.citation: Infect Immun. 1993 Nov;61(11):4818-27
references.pmid: 8406883
references.citation: Infect Immun. 1988 Feb;56(2):419-23
references.pmid: 3276625
references.citation: Infect Immun. 1990 Feb;58(2):443-8
references.pmid: 2404872
references.citation: Lancet. 1987 May 9;1(8541):1049-52
references.pmid: 2883393